We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
TVGN | Tevogen Bio Holdings Inc | 1.50 | 0.65 | 76.47% | 775,046 |
BCSAU | Blockchain Coinvestors Acquisition Corporation I | 16.71 | 5.46 | 48.53% | 109 |
FRGT | Freight Technologies Inc | 1.325 | 0.4113 | 45.01% | 1,806,756 |
PEGY | Pineapple Energy Inc | 0.0701 | 0.0182 | 35.07% | 9,146,403 |
COMM | CommScope Holding Company Inc | 1.18 | 0.2653 | 29.00% | 10 |
GGLL | Direxion Daily GOOGL Bull 2X ETF | 44.23 | 8.21 | 22.79% | 1,622 |
RELI | Reliance Global Group Inc | 0.34 | 0.06 | 21.43% | 11 |
ELWS | Earlyworks Co Ltd | 0.8899 | 0.15455 | 21.02% | 76,602 |
PRTG | Portage Biotech Inc | 0.2799 | 0.0429 | 18.10% | 2 |
VCNX | Vaccinex Inc | 7.00 | 1.07 | 18.02% | 1 |
MBOT | Microbot Medical Inc | 0.9996 | 0.1364 | 15.80% | 400 |
First patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat)1 for early COVID-19 outpatient treatment, funded through non-dilutive external sources, including the U.S. Department of Defense The study is expected to be completed by the end of 2024 RHB-107 successfully met the primary endpoint of safety and tolerability and delivered promising efficacy results, including marked reduction in hospitalization due to COVID-19 in a U.S. Phase 2 study2 RHB-107 is a novel, oral, once-daily, host-directed potential broad-acting antiviral expected to act independently of viral spike protein mutations3 RALEIGH, N.C. and TEL-AVIV, Israel, April 24, 2024 /PRNewswire/ ...
reAlpha Tech Corp. (“reAlpha”) (Nasdaq: AIRE), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, today announced the launch of Claire, the real estate industry’s first generative AI-powered, zero-commission Smart Buyer’s Agent.
BEIJING, April 25, 2024 /PRNewswire/ -- Recon Technology, Ltd. (NASDAQ: RCON) ("Recon" or the "Company") announced today that the Company's shareholders approved on March 29, 2024 to effect a reverse stock split of the Company's Class A ordinary shares at the ratio of one-for-eighteen with the market effective date of May 1, 2024.
WestPark Capital today announced the closing of a $6,000,000 IPO for CDT Environmental Technology Investment Holdings Limited (“CDT”). CDT is a waste treatment company that designs, develops, manufactures, sells, installs, operates and maintains sewage treatment systems and provides sewage treatment services in China. The IPO consisted of 1,500,000 ordinary shares at a public offering price of $4.00 per share resulting in gross proceeds of $6,000,000, before offering expenses.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 64,421.99 | -62.65 | -0.10% | 1.26T | 3,940,570,399 |
ETH | Ethereum | 3,142.89 | -12.98 | -0.41% | 377.65B | 1,978,473,508 |
USDT | Tether USD | 0.99993 | 0.00016 | 0.02% | 97.83B | 243,003,671 |
BNB | Binance Coin | 608.07 | -5.17 | -0.84% | 96.14B | 346,280,545 |
SOL | Solana | 144.11 | -0.670 | -0.46% | 63.54B | 1,166,370,846 |
STETH | stETH | 3,139.31 | -0.468519 | -0.01% | 30.78B | 1,181,854 |
XRP | Ripple | 0.5249 | -0.0004 | -0.08% | 28.68B | 309,331,047 |
USDC | USD Coin | 0.9999 | 0.00 | 0.00% | 28.07B | 1,029,218,676 |
DOGE | Dogecoin | 0.15096 | -0.00031 | -0.20% | 21.63B | 296,922,469 |
TONCOIN | Wrapped TON Coin | 5.39 | -0.027246 | -0.50% | 18.64B | 80,262,529 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions